SCHEMBL4242355

SCHEMBL4242355

Cc1ccccc1-n1c(CCCN)nc2ccsc2c1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 3/20 0.57
PDE4B Q07343 2/20 0.48
PDE4D Q08499 2/20 0.48
PDE4A P27815 1/20 0.48
PDE4C Q08493 1/20 0.48
PDE3B Q13370 1/20 0.48
PDE3A Q14432 1/20 0.48
PDE10A Q9Y233 1/20 0.44
ALDH1A1 P00352 6/20 0.44
PDE7A Q13946 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
LMNA P02545 3/20 0.41
MAPT P10636 2/20 0.41
KDM4E B2RXH2 1/20 0.41
HPGD P15428 1/20 0.41
POLB P06746 2/20 0.41
KIF11 P52732 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.39
MEN1 O00255 1/20 0.39
GAA P10253 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4242198 0.89 PIK3CD (0.56) PIK3CDPDE4BPDE4DPDE4APDE4C
SCHEMBL7509324 0.84 PIK3CD (0.52) PIK3CDPDE4BPDE4DPDE4APDE4C
SCHEMBL4234298 0.83 ALDH1A1 (0.55) PIK3CDPDE4BPDE4DPDE4APDE4C
SCHEMBL1703442 0.83 PIK3CD (0.57) PIK3CDPDE4BPDE4DPDE4APDE4C
SCHEMBL4229400 0.81 POLB (0.51) PDE4BPDE4DPDE4APDE4CPDE3B
SCHEMBL7512190 0.81 PIK3CD (0.54) PIK3CDPDE4BPDE4DPDE4APDE4C
SCHEMBL16585042 0.80 PIK3CD (0.86) PIK3CDPDE4DPDE10AALDH1A1LMNA
SCHEMBL4234481 0.80 PDE10A (0.45) PIK3CDPDE4BPDE4DPDE4APDE4C
SCHEMBL6222959 0.79 ALDH1A1 (0.63) PIK3CDPDE4BALDH1A1PDE7ASMN1; SMN2
SCHEMBL4229663 0.76 USP2 (0.53) PDE4BPDE4DPDE4APDE4CPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2097422-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS Eli Lilly & Co. (US) 2009-09-09 EP disclosed
WO-2008064018-A1 THIENOPYRIMIDINONES FOR TREATMENT OF INFLAMMATORY DISORDERS AND CANCERS ELI LILLY & CO. (US) 2008-05-29 WO disclosed